Validation of the xylazine/ketamine anesthesia test as a predictor of the emetic potential of pharmacological compounds in rats. (23rd April 2019)

• Record Type: Journal Article
• Authors: Nelissen, Ellis; van Goethem, Nick P.; Bonassoli, Vivian T.; Heckman, Pim R.A.; van Hagen, Britt T.J.; Suay, Dila; Wouters, Caroline; Prickaerts, Jos
• Is Part Of: Neuroscience letters. Volume 699(2019)
• Page Start: 41
• Page End: 46
• Publication Date: 2019-04-23
• Subjects: α2 adrenergic receptor -- Emesis -- Ketamine -- Xylazine -- Phosphodiesterase -- Nausea; Neurology -- Periodicals; Neurology -- Periodicals; Research -- Periodicals; Neurologie -- Périodiques; Neuroanatomie -- Périodiques; Neuropharmacologie -- Périodiques; Neurophysiologie -- Périodiques; Neurology; Periodicals; Electronic journals; 617.48
• DOI: 10.1016/j.neulet.2019.01.026
• Languages: English
• ISSNs: 0304-3940

Abstract

Highlights: Rolipram, yohimbine, and clonidine reduced xylazine/ketamine anesthesia duration. Haloperidol and imipramine lengthened the duration of anesthesia. Ondansetron was unable to rescue a reduction in anesthesia duration. Abstract: The xylazine/ketamine anesthesia test is widely used as a predictor of the emetic potential of pharmacological compounds in rats. An emetic reflex is usually triggered by the emetic center, which is populated with many different chemoreceptors. Inhibition of the α2 adrenergic receptor (α2 receptor) is involved in the initiation of the emetic reflex, and this is the key mechanism behind the xylazine/ketamine anesthesia test. In this study, we attempt to validate this test as a predictor of the emetic potential of pharmacological compounds. Furthermore, it was investigated whether an anti-emetic potential of pharmacological compounds could be assessed within this test as well. Rats were anesthetized with a combination of low doses of ketamine and xylazine, and subsequently treated with PDE4 inhibitor rolipram, α2 receptor antagonist yohimbine, α2 receptor agonist clonidine, tricyclic antidepressant imipramine, D2-receptor antagonist haloperidol, or 5-HT3 receptor antagonist (and anti-emetic drug) ondansetron. We were able to successfully reproduce the reduction in anesthesia time after rolipram or yohimbine treatment, as found in previous studies and has been suggested to be indicative of emetic properties of these treatments is humans. Furthermore, clonidine shortened anesthesia duration whereas imipramine and haloperidol lengthened anesthesia duration. Ondansetron was unable to rescue the reduction in duration of anesthesia induced by either rolipram or yohimbine. Altogether, the xylazine/ketamine anesthesia test is a reliable measure for α2 receptor antagonism. However, it may not be appropriate to assess emesis independent of this mechanism.